16.11.2017 23:49:00
|
Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2017
LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Rheumatoid Arthritis patients study in a new report 'Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2017'.
Download the full report: https://www.reportbuyer.com/product/3895275
The report provides insights into Rheumatoid Arthritis epidemiology, Rheumatoid Arthritis diagnosed patients, and Rheumatoid Arthritis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Rheumatoid Arthritis derived from epidemiological analysis, percentage of patients diagnosed with Rheumatoid Arthritis, and percentage of patients treated with a therapy.
The study helps executives estimate Rheumatoid Arthritis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Rheumatoid Arthritis prevalence, Rheumatoid Arthritis diagnosis rate, and Rheumatoid Arthritis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.
Key Features of the Report:
- Rheumatoid Arthritis Patient Flow
- Rheumatoid Arthritis Prevalence
- Rheumatoid Arthritis Diagnosed Patients
- Rheumatoid Arthritis Treated Patients
Download the full report: https://www.reportbuyer.com/product/3895275
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/global-rheumatoid-arthritis-epidemiology-and-patient-flow-analysis---2017-300558244.html
SOURCE ReportBuyer
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!